Monday, April 4, 2016

How will new tax rules impact Pfizer-Allergan deal?

Raghuram Selvaraju from Rodman & Renshaw explains that Pfizer could have second thoughts about acquiring Allergan if tax benefits are negated.

from Mergers and Acquisitions http://ift.tt/1Sxq2Tr
Posted by at
Labels: ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)